Combined phase I & II trial done for –
## Core Concept
The question pertains to the different phases of clinical trials, specifically focusing on the scenarios in which Phase I and Phase II trials are combined. Clinical trials are crucial for evaluating the safety and efficacy of new drugs or treatments. Phase I trials primarily assess safety, tolerability, and pharmacokinetics, while Phase II trials evaluate the efficacy and side effects.
## Why the Correct Answer is Right
The correct answer involves understanding that a combined Phase I and II trial is typically conducted when the investigational product has already shown promise in preclinical studies or when there is a strong scientific rationale for its potential efficacy and safety profile. This approach is often taken for drugs that have a well-understood mechanism of action and have shown significant benefits in animal models or in vitro studies. It aims to expedite the development process while ensuring that the drug is safe and shows preliminary evidence of efficacy.
## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it does not accurately represent a scenario where combining Phase I and II trials is standard practice.
- **Option B:** Similarly, this option does not align with the typical indications for a combined Phase I and II trial.
- **Option D:** This option is also incorrect as it does not reflect a situation where a combined approach is commonly adopted.
## Clinical Pearl / High-Yield Fact
A key point to remember is that combined Phase I and II trials are often used in the development of **oncology drugs**. This is because these drugs usually have a strong preclinical rationale and the goal is to quickly assess their safety and efficacy in patients with limited treatment options.
## Correct Answer Line
**Correct Answer: C.**